Albumin-bound paclitaxel forms a novel nanoparticle formulation with albumin as a carrier to circumvent the problem that paclitaxel itself is extremely insoluble in water (21), which significantly reduces the allergic reactions caused by paclitaxel with a higher concentration in tumor tissues, therefore bringing more clinical efficacy and less toxic side effects to cancer patients (22). The gene discussed is ALB; the disease is cancer.